Chargement en cours...
Early intervention with tafamidis provides long-term (5.5-year) delay of neurologic progression in transthyretin hereditary amyloid polyneuropathy
Transthyretin hereditary amyloid polyneuropathy, also traditionally known as transthyretin familial amyloid polyneuropathy (ATTR-FAP), is a rare, relentless, fatal hereditary disorder. Tafamidis, an oral, non-NSAID, highly specific transthyretin stabilizer, demonstrated safety and efficacy in slowin...
Enregistré dans:
| Publié dans: | Amyloid |
|---|---|
| Auteurs principaux: | , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Taylor & Francis
2016
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5359776/ https://ncbi.nlm.nih.gov/pubmed/27494299 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/13506129.2016.1207163 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|